The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/β-catenin signaling pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/β-catenin signaling pathway
Authors
Keywords
-
Journal
Cancer Cell International
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-26
DOI
10.1186/s12935-019-1010-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer
- (2019) Sara Monteiro-Reis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Long noncoding RNA DLX6‐AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR‐424‐5p
- (2019) Dan Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer
- (2019) Margaritis Avgeris et al. CARCINOGENESIS
- Long noncoding RNA DLX6-AS1 promotes tumorigenesis by modulating miR-497-5p/FZD4/ FZD6/Wnt/β-catenin pathway in pancreatic cancer
- (2019) Jiyong Yang et al. Cancer Management and Research
- Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells
- (2019) Dong-Mei Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial–mesenchymal transition in gastric cancer
- (2019) Yu Liang et al. Gastric Cancer
- DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1
- (2019) Qiong Wu et al. CANCER BIOLOGY & THERAPY
- LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway
- (2018) Zhiyong Tuo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
- (2018) Nithya Krishnamurthy et al. CANCER TREATMENT REVIEWS
- mRNA, microRNA and lncRNA as novel bladder tumor markers
- (2018) Edyta Wieczorek et al. CLINICA CHIMICA ACTA
- Atezolizumab and bladder cancer: facing a complex disease
- (2018) Carlo Cattrini et al. LANCET
- Robot-assisted versus open cystectomy
- (2018) Roland Seiler et al. LANCET
- LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer
- (2018) Yong An et al. Cancer Cell International
- LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment
- (2018) Changhao Chen et al. Nature Communications
- LncRNA DLX6-AS1/miR-129-5p/DLK1 axis aggravates stemness of osteosarcoma through Wnt signaling
- (2018) Rong-mou Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer
- (2018) Yongjie Huang et al. BIOMEDICINE & PHARMACOTHERAPY
- LncRNA miR143HG suppresses bladder cancer development through inactivating Wnt/β-catenin pathway by modulating miR-1275/AXIN2 axis
- (2018) Hui Xie et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer
- (2018) David T Miyamoto et al. LANCET ONCOLOGY
- Neoadjuvant pembrolizumab in bladder cancer
- (2018) Elizabeth Gourd LANCET ONCOLOGY
- Exosome–transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression
- (2018) Rui Zheng et al. Molecular Cancer
- Knockdown of lncRNA SNHG7 inhibited cell proliferation and migration in bladder cancer through activating Wnt/β-catenin pathway
- (2018) Yi Chen et al. PATHOLOGY RESEARCH AND PRACTICE
- LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis
- (2018) Jing Quan et al. OncoTargets and Therapy
- Long noncoding RNA neuroblastoma-associated transcript 1 gene inhibits malignant cellular phenotypes of bladder cancer through miR-21/SOCS6 axis
- (2018) Zhongyuan Liu et al. Cell Death & Disease
- Long noncoding RNA DLX6-AS1 accelerates the glioma carcinogenesis by competing endogenous sponging miR-197-5p to relieve E2F1
- (2018) Xiangpan Li et al. GENE
- New option for cisplatin-ineligible urothelial cancer
- (2017) Robert Dreicer LANCET ONCOLOGY
- Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway
- (2017) Zhijun Pei et al. Oncotarget
- Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
- (2016) Jakub Dobruch et al. EUROPEAN UROLOGY
- Bladder cancer
- (2016) Ashish M Kamat et al. LANCET
- Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma
- (2015) Juan Li et al. Cancer Cell International
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More